William Slayton, MD - Research

Research at a glance

Top areas of exploration

Hematopoietic Stem Cells , 12 publications
Bone Marrow Transplantation , 10 publications
Bone Marrow Cells , 9 publications
Hematopoietic Stem Cell Transplantation , 8 publications

Research activity

86 publications

2,301 citations

Why is this important?

Active clinical trials

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other鈥�

Investigators: Brian Stover, William Slayton
Status: Accepting Candidates
Ages: 3 Years - 29 Years
Sexes: All

A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in P

This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common鈥�

Investigators: Brian Stover, William Slayton
Status: Accepting Candidates
Ages: 2 Years - 25 Years
Sexes: All

A Study Comparing Blinatumomab to Blinatumomab With Nivolumab in Patients With First Relapse B-ALL

This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come back (relapsed). Down syndrome patients with鈥�

Investigator: William Slayton
Status: Accepting Candidates
Ages: 1 Year - 30 Years
Sexes: All

My publications

86 publications

2020

Primary pulmonary artery sarcoma in the pediatric patient: Review of literature and a case report.

Radiology case reports

鈥�

2019

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients.

Blood advances

鈥�

2019

Functional Improvement of Chimeric Antigen Receptor Through Intrinsic Interleukin-15R伪 Signaling.

Current gene therapy

鈥�

2018

Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

鈥�

2017

Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.

Thrombosis and haemostasis

鈥�

网红黑料